COMMUNIQUÉS West-GlobeNewswire

High Survival Rates With Ryoncil® in EIND Program Emphasize Importance of Earlier Use in Both Children and Adults With SR-aGvHD
12/02/2026
NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided data presented at the February 2026 Tandem [...]
Vaxcyte Doses First Participants in OPUS-3 Phase 3 Trial Evaluating VAX-31 in Adults Previously Vaccinated with Lower-Valency Pneumococcal Vaccines
11/02/2026
Company Expects to Report Topline Data from OPUS-3 Trial and OPUS-2 Phase 3 Trial Evaluating Concomitant Administration of VAX-31 and a Seasonal Influenza Vaccine in First Half of 2027 OPUS-1, VAX-31 Adult Phase 3 [...]
Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results
11/02/2026
SAN JOSE, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and [...]
Etienna Bio, Inc. Announces Formation of Scientific Advisory Board with Renowned UMass Chan Leaders
11/02/2026
Silvia Corvera, MD, and Michael Czech, PhD, Join SAB to Advance Autologous Regenerative Cell Platform LEAWOOD, Kan., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Etienna Bio, Inc., a regenerative biotechnology company developing [...]
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11/02/2026
SOUTH SAN FRANCISCO, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc., or BBOT (NASDAQ: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today [...]
Tectonic Therapeutic to Host Virtual KOL Event and Discussion of TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia, on February 24, 2026
11/02/2026
WATERTOWN, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc . (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and [...]
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
11/02/2026
Launch of Inspire V system complete with strong revenue and profitability performance in the fourth quarter and FDA approval for 3.0T MRI compatibility Fourth quarter revenue growth of 12% and full year revenue growth [...]
MemoTril Product Information Updated as Consumer Interest in Brain Health and Cognitive Support Supplement Options Grows in 2026
11/02/2026
Examining MemoTril ingredient disclosures, category context for brain health and memory support supplements, and the transparency factors consumers consider when comparing cognitive support options in 2026 New York, NY [...]
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
11/02/2026
Bagsværd, Denmark, 11 February 2026 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance [...]
Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA
11/02/2026
REDWOOD CITY, CA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company”), an innovative Technology-as-a-Service (TaaS) company committed to transforming chronic condition [...]
VALNEVA Declaration of shares and voting rights: January 31, 2026
11/02/2026
VALNEVA Declaration of shares and voting rights January 31, 2026 __________________________________________________________________________________________ Company name: VALNEVA Registered office: Îlot Saint-Joseph [...]
Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies
11/02/2026
CHICAGO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced the expansion of its digital [...]
VALNEVA Déclaration d’actions et de droits de vote : 31 janvier 2026
11/02/2026
VALNEVA Déclaration d’actions et de droits de vote 31 janvier 2026 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : Îlot [...]
EssilorLuxottica: Résultats T4 et annuels 2025 - Hausse de +18,4 % du chiffre d'affaires au T4 et de +11,2 % sur l'exercice. Marge opérationnelle ajustée à 16,0 % sur l'exercice
11/02/2026
Hausse de +18,4 % du chiffre d'affaires 1 au T4 et de +11,2 % sur l'exercice Marge opérationnelle ajustée 1,2 à 16,0 % sur l'exercice Chiffre d’affaires annuel du Groupe à 28 491 millions d’euros, +11,2 % à taux de [...]
Entirety Biomedical Closes $1.2 Million Seed Financing to Advance Absorbable Magnesium Implants for Orthopedic Fixation
11/02/2026
DETROIT, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Entirety Biomedical, a Michigan-based medical device startup developing bioabsorbable implant systems with its proprietary Curasorb technology, today announced the closing of a [...]
CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH
11/02/2026
CHEYENNE, Wyo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX) (“CS Group” or the “Company”), a medical technology and hygiene solutions company, today announced the appointment of Shah Teelani [...]
Alvotech Announces Increase in Number of Own Shares
11/02/2026
REYKJAVIK, ICELAND (February 11, 2026) — Alvotech (NASDAQ: ALVO) (the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, has increased [...]
Booking Health Releases 2026 Global Overview of Leading Cancer Hospitals Amid Growing Demand for International Oncology Care
11/02/2026
Langenfeld, Germany, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Booking Health , an international medical travel coordination service, today released a comprehensive 2026 overview of leading cancer hospitals worldwide, [...]
OKYO Pharma Announces Transition of At-The-Market Equity Offering Facility to Leerink Partners
11/02/2026
LONDON and NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]

Pages